Seres Therapeutics, Inc. (MCRB) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Seres Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Seres Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.02B, a 8.84% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.02B -$82.7M -8.84% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$978M -$114M -13.2% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$937M -$141M -17.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$889M -$153M -20.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$936M -$265M -39.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$865M -$250M -40.7% Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$796M -$231M -41% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$736M -$103M -16.3% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 -$671M -$86.7M -14.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 -$614M -$65.6M -12% Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$564M -$33.8M -6.38% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$633M -$132M -26.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 -$584M -$105M -21.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 -$549M -$89.1M -19.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$531M -$89.7M -20.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$500M -$75.8M -17.9% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 -$480M -$65.8M -15.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$460M -$70.3M -18% Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$441M -$72.8M -19.8% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$424M -$78.3M -22.6% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 -$414M -$95.4M -30% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 -$389M -$126M -47.7% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$368M -$133M -56.9% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$346M -$118M -52% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 -$318M -$119M -59.4% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$264M -$89.4M -51.3% Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$235M -$85.7M -57.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$228M -$97.5M -74.8% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$200M -$97.3M -95.1% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 -$174M -$91.6M -111% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$149M -$85.9M -136% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$130M -$81.9M -169% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 -$102M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 -$82.6M -$54.8M -197% Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$63M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$48.4M Jun 30, 2015 10-Q 2015-08-10
Q4 2014 -$27.8M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.